Replimune (REPL) Net Equity Issued and Repurchased (2018 - 2026)
Replimune (REPL) recorded Net Equity Issued and Repurchased of $1 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $8,000 a year earlier and up 990.2% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
On a TTM basis, Replimune's Net Equity Issued and Repurchased came in at $1.88 million as of Jun 30, 2026, down 96.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $883,000, down 99.1% from FY2025.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -68.5% (FY2021 to FY2026).
- Across earlier fiscal years, Net Equity Issued and Repurchased came in at $97 million in FY2025, $1.76 million in FY2024 (-98.8%), $149.85 million in FY2023 and $6.86 million in FY2022 (-97.6%).
- The fiscal Q1 2027 figure is the highest quarterly Net Equity Issued and Repurchased since fiscal Q3 2025.
- Per Business Quant, the preceding three fiscal quarters came in at $92,000 (Q4 2026), $282,000 (Q3 2026) and $501,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Replimune | 1.14 Bn | 79.22 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 282,000.00 |
| Sep 30, 2025 | 501,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 48.74 Mn |
| Jun 30, 2024 | 48.50 Mn |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 551,000.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 130.24 Mn |
| Dec 31, 2022 | 6.70 Mn |
| Sep 30, 2022 | 6.70 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 1.21 Mn |
| Jun 30, 2021 | 1.17 Mn |
API Access
Replimune Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();